GlobeNewswire Inc.··NaAlpha Tau Completes Pivotal Study for Skin Cancer Treatment, Targeting FDA Approval
Alpha Tau Medical completes enrollment of 88 patients in pivotal skin cancer trial, advancing toward FDA approval of Alpha DaRT® for recurrent squamous cell carcinoma.
DRTSDRTSWFDA approvalclinical study